Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 5Phase 2/3 2Phase 1/2 2Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 16Colorectal Neoplasms 8Stomach Neoplasms 6Carcinoma, Hepatocellular 5Pancreatic Neoplasms 4Neoplasm Metastasis 4Biliary Tract Neoplasms 4Rectal Neoplasms 3Neoplasms 3Esophageal Neoplasms 3Colonic Neoplasms 3Esophageal Squamous Cell Carcinoma 2Adenocarcinoma Of Esophagus 2Triple Negative Breast Neoplasms 1Resected Liver Metastases From Colorectal Cancer 1Recurrence 1Quality of Life 1Oesophagogastric Cancer 1Malignant Tumor of Pancreas Metastatic to Liver 1Inflammatory Breast Neoplasms 1HER2-positive Gastric Cancer 1HER2-positive Breast Cancer 1Gastroesophageal Junction Adenocarcinoma 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Breast Diseases 1Bile Duct Neoplasms 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Nivolumab 3Ramucirumab 2Radiotherapy 2Paclitaxel 2Cisplatin 2Capecitabine 2tucatinib 1Trastuzumab 1Taxes 1Specimen Handling 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Folfox protocol 1Fluorouracil 1Drug Therapy 1Cetuximab 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Adenocarcinoma Of Esophagus × Capecitabine × Clear all
NCT01404156 2024-08-28

POWERRANGER

CancerCare Manitoba

Phase 2/3 Completed
29 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Wales Cancer Trials Unit

Phase 2/3 Unknown
259 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡